Mitochondrial dysfunction in neurodegenerative disorders.

[1]  A. Schapira,et al.  Evidence for mitochondrial dysfunction in Parkinson's disease—a critical appraisal , 2004, Movement disorders : official journal of the Movement Disorder Society.

[2]  A. Hackam,et al.  Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates , 1998, Nature Genetics.

[3]  Olaf Riess,et al.  AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease , 1998, Nature Genetics.

[4]  P Trouillas,et al.  Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes. , 1997, Human molecular genetics.

[5]  A. Munnich,et al.  Aconitase and mitochondrial iron–sulphur protein deficiency in Friedreich ataxia , 1997, Nature Genetics.

[6]  S. W. Davies,et al.  Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. , 1997, Science.

[7]  M. MacDonald,et al.  Frataxin gene of Friedreich's ataxia is targeted to mitochondria , 1997, Annals of neurology.

[8]  Michel Koenig,et al.  Studies of human, mouse and yeast homologues indicate a mitochondrial function for frataxin , 1997, Nature Genetics.

[9]  Robert B. Wilson,et al.  Respiratory deficiency due to loss of mitochondrial DNA in yeast lacking the frataxin homologue , 1997, Nature Genetics.

[10]  Mark Turmaine,et al.  Formation of Neuronal Intranuclear Inclusions Underlies the Neurological Dysfunction in Mice Transgenic for the HD Mutation , 1997, Cell.

[11]  Robert L. Nussbaum,et al.  Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .

[12]  M. Pandolfo,et al.  Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin. , 1997, Science.

[13]  C. Marsden,et al.  Mitochondrial respiratory chain function in multiple system atrophy , 1997, Movement disorders : official journal of the Movement Disorder Society.

[14]  F. Andermann,et al.  Phenotypic variability in friedreich ataxia: Role of the associated GAA triplet repeat expansion , 1997, Annals of neurology.

[15]  M. Beal,et al.  Oxidative damage and metabolic dysfunction in Huntington's disease: Selective vulnerability of the basal ganglia , 1997, Annals of neurology.

[16]  H. Lehrach,et al.  HIP-I: a huntingtin interacting protein isolated by the yeast two-hybrid system. , 1997, Human molecular genetics.

[17]  T. Gibson,et al.  Friedreich's ataxia protein: phylogenetic evidence for mitochondrial dysfunction , 1996, Trends in Neurosciences.

[18]  S. W. Davies,et al.  Exon 1 of the HD Gene with an Expanded CAG Repeat Is Sufficient to Cause a Progressive Neurological Phenotype in Transgenic Mice , 1996, Cell.

[19]  A Dürr,et al.  Clinical and genetic abnormalities in patients with Friedreich's ataxia. , 1996, The New England journal of medicine.

[20]  R. Swerdlow,et al.  Origin and functional consequences of the complex I defect in Parkinson's disease , 1996, Annals of neurology.

[21]  G Campanella,et al.  The relationship between trinucleotide (GAA) repeat length and clinical features in Friedreich ataxia. , 1996, American journal of human genetics.

[22]  J. Hodgson,et al.  Huntingtin Is Ubiquitinated and Interacts with a Specific Ubiquitin-conjugating Enzyme* , 1996, The Journal of Biological Chemistry.

[23]  Xiaodong Wang,et al.  Induction of Apoptotic Program in Cell-Free Extracts: Requirement for dATP and Cytochrome c , 1996, Cell.

[24]  G. Kroemer,et al.  Apoptosis-associated derangement of mitochondrial function in cells lacking mitochondrial DNA. , 1996, Cancer research.

[25]  G. Kroemer,et al.  Mitochondrial control of nuclear apoptosis , 1996, The Journal of experimental medicine.

[26]  J. Cooper,et al.  Mitochondrial defect in Huntington's disease caudate nucleus , 1996, Annals of neurology.

[27]  A. Roses,et al.  Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH , 1996, Nature Medicine.

[28]  J. Crapo,et al.  Requirement for Superoxide in Excitotoxic Cell Death , 1996, Neuron.

[29]  H. Reichmann,et al.  Mitochondrial disorders in degenerative ataxias , 1996 .

[30]  S. Snyder,et al.  A huntingtin-associated protein enriched in brain with implications for pathology , 1995, Nature.

[31]  P. Allen,et al.  Generalized mitochondrial dysfunction in Parkinson's disease detected by magnetic resonance spectroscopy of muscle , 1995, Neurology.

[32]  Virginia E. Papaioannou,et al.  Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue , 1995, Nature Genetics.

[33]  G. Kroemer,et al.  Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death , 1995, The Journal of experimental medicine.

[34]  A. Harding,et al.  Pedigree analysis in Leber hereditary optic neuropathy families with a pathogenic mtDNA mutation. , 1995, American journal of human genetics.

[35]  Robert Hill,et al.  Low platelet mitochondrial complex I and complex II/III activity in early untreated parkinson's disease , 1995, Annals of neurology.

[36]  A. Hausladen,et al.  Superoxide and peroxynitrite inactivate aconitases, but nitric oxide does not. , 1994, The Journal of biological chemistry.

[37]  W J Lance,et al.  Mitochondrial Disorders in Neurology , 1994 .

[38]  C. Marsden,et al.  Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia , 1994, Annals of neurology.

[39]  C. Marsden,et al.  A 31P magnetic resonance spectroscopy study of mitochondrial function in skeletal muscle of patients with Parkinson's disease , 1994, Journal of the Neurological Sciences.

[40]  S. Moncada,et al.  Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide , 1994, FEBS letters.

[41]  R. Sakuta,et al.  Accumulation of mtDNA with a mutation at position 3271 in tRNA(Leu)(UUR) gene introduced from a MELAS patient to HeLa cells lacking mtDNA results in progressive inhibition of mitochondrial respiratory function. , 1993, Biochemical and biophysical research communications.

[42]  J. Cooper,et al.  Myopathy in vitamin E deficient rats: muscle fibre necrosis associated with disturbances of mitochondrial function. , 1993, Journal of anatomy.

[43]  J. Cooper,et al.  Iron induced oxidative stress and mitochondrial dysfunction: relevance to Parkinson's disease , 1993, Brain Research.

[44]  I. Nonaka,et al.  MELAS mutation in mtDNA binding site for transcription termination factor causes defects in protein synthesis and in respiration but no change in levels of upstream and downstream mature transcripts. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[45]  C. Marsden,et al.  Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease. , 1992, Brain : a journal of neurology.

[46]  J. Cooper,et al.  Irreversible Inhibition of Mitochondrial Complex I by 1‐Methyl‐4‐Phenylpyridinium: Evidence for Free Radical Involvement , 1992, Journal of neurochemistry.

[47]  M. Beal,et al.  Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? , 1992, Annals of neurology.

[48]  N. Bresolin,et al.  In vitro genetic transfer of protein synthesis and respiration defects to mitochondrial DNA-less cells with myopathy-patient mitochondria. , 1991, Molecular and cellular biology.

[49]  C. Marsden,et al.  Anatomic and Disease Specificity of NADH CoQ1 Reductase (Complex I) Deficiency in Parkinson's Disease , 1990, Journal of neurochemistry.

[50]  K. Davies,et al.  The oxidative inactivation of mitochondrial electron transport chain components and ATPase. , 1990, The Journal of biological chemistry.

[51]  Y. Agid,et al.  Mitochondrial function and parental sex effect in Huntington's disease , 1990, The Lancet.

[52]  Douglas C. Miller,et al.  A large kindred with autosomal dominant Parkinson's disease , 1990, Annals of neurology.

[53]  M. King,et al.  Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation. , 1989, Science.

[54]  G. Finocchiaro,et al.  Glucose metabolism alterations in Friedreich's ataxia , 1988, Neurology.

[55]  F. Foury,et al.  A nuclear mutant of Saccharomyces cerevisiae deficient in mitochondrial DNA replication and polymerase activity. , 1986, The Journal of biological chemistry.

[56]  A. Myers,et al.  Mitochondrial protein synthesis is required for maintenance of intact mitochondrial genomes in Saccharomyces cerevisiae. , 1985, The EMBO journal.

[57]  A. Barbeau.  The Quebec Cooperative Study of Friedreich's Ataxia: 1974-1984 — 10 Years of Research , 1984, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[58]  R. Roos,et al.  Nuclear membrane indentations in Huntington's chorea , 1983, Journal of the Neurological Sciences.

[59]  J. Lancaster,et al.  Nitrite inhibition of Clostridium botulinum: electron spin resonance detection of iron-nitric oxide complexes. , 1983, Science.

[60]  Diana Brahams,et al.  Medicine and the Law , 1983, The Lancet.

[61]  H. M. Hittner,et al.  Linkage studies in carriers of Lowe oculo-cerebro-renal syndrome. , 1982, American journal of human genetics.

[62]  J. Meyer.  Comparison of carbon monoxide, nitric oxide, and nitrite as inhibitors of the nitrogenase from Clostridium pasteurianum. , 1981, Archives of biochemistry and biophysics.

[63]  Menon Nk,et al.  Low Activities of the Pyruvate and Oxoglutarate Dehydrogenase Complexes in Five Patients with Friedreich's Ataxia , 1976 .

[64]  W. Engel,et al.  Pyruvate oxidation in neuromuscular diseases , 1974, Neurology.

[65]  B Chance,et al.  The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen. , 1973, The Biochemical journal.

[66]  M. Zeviani,et al.  Complex I deficiency is associated with 3243G:C mitochondrial DNA in osteosarcoma cell cybrids. , 1996, Human molecular genetics.

[67]  C. Marsden,et al.  Mitochondrial function in Parkinson's disease , 1992, Annals of neurology.